Rofecoxib and octreotide combine to stop gastric cancer cell proliferation.
Publication: Health & Medicine Week
Publication Date: 27-DEC-04
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
2004 DEC 27 - (NewsRx.com & NewsRx.net) -- Rofecoxib and octreotide combine to stop gastric cancer cell proliferation.
"Our previous studies indicated that cyclooxygenase-2 inhibitor or octreotide could suppress the proliferation of gastric adenocarcinoma in vitro or in vivo. The present study was aimed to find whether rofecoxib combined with octreotide could enhance the inhibitive effects on the growth of gastric cancer....
Read the full article for free courtesy of your local library.
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
